Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in Sorafenib-Refractory Metastatic RCC
NCT00282048Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Mar 2006; status: completed.
02
Drugs
axitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00282048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282048.